Increased Connexin 43 Expression as a Potential Mediator of the Neuroprotective Activity of the Corticotropin-Releasing Hormone

被引:31
作者
Hanstein, Regina [1 ]
Trotter, Jacqueline [2 ]
Behl, Christian [1 ]
Clement, Angela B. [1 ]
机构
[1] Johannes Gutenberg Univ Mainz, Inst Pathobiochem, Univ Med Ctr, D-55099 Mainz, Germany
[2] Johannes Gutenberg Univ Mainz, Dept Biol, Unit Mol Cell Biol, D-55099 Mainz, Germany
关键词
PROTEIN-KINASE-C; GAP JUNCTIONAL COMMUNICATION; CULTURED CARDIAC MYOCYTES; OXIDATIVE STRESS; CELL-DEATH; INTERCELLULAR COMMUNICATION; TRANSCRIPTION FACTORS; FACTOR CRF; HIPPOCAMPAL-NEURONS; SIGNALING PATHWAYS;
D O I
10.1210/me.2009-0022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
CRH is a major central stress mediator, but also a potent neuroprotective effector. The mechanisms by which CRH mediates its neuroprotective actions are largely unknown. Here, we describe that the gap junction molecule connexin43 (Cx43) mediates neuroprotective effects of CRH toward experimentally induced oxidative stress. An enhanced gap junction communication has been reported to contribute to neuroprotection after neurotoxic insults. We show that CRH treatment up-regulates Cx43 expression and gap junctional communication in a CRH receptor-dependent manner in IMR32 neuroblastoma cells, primary astrocytes, and organotypic hippocampal slice cultures. MAPKs and protein kinase A-cAMP response element binding protein-coupled pathways are involved in the signaling cascade from CRH to enhanced Cx43 function. Inhibition of CRH-promoted gap junction communication by the gap junction inhibitor carbenoxolone could prevent neuroprotective actions of CRH in cell and tissue culture models suggesting that gap junction molecules are involved in the neuroprotective effects of CRH. The extent of oxidative stress-induced protein carbonylation and cell death inversely correlated with Cx43 protein levels as shown by Cx43 small interfering RNA knockdown experiments. Coculture studies of primary neurons and astrocytes revealed that astrocytic Cx43 likely contributes to the neuroprotective effects of CRH. To our knowledge this is the first description of Cx43 as a potential mediator of the neuroprotective actions of CRH. (Molecular Endocrinology 23: 1479-1493, 2009)
引用
收藏
页码:1479 / 1493
页数:15
相关论文
共 86 条
[1]   The CRF-like peptide urocortin greatly attenuates loss of extracellular striatal dopamine in rat models of Parkinson's disease by activating CRF1 receptors [J].
Abuirmeileh, Amjad ;
Harkavyi, Alexander ;
Kingsbury, Ann ;
Lever, Rebecca ;
Whitton, Peter S. .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 604 (1-3) :45-50
[2]   CRF stimulates expression of multiple fos and jun related genes in the AtT-20 corticotroph cell [J].
Autelitano, DJ ;
Cohen, DR .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1996, 119 (01) :25-35
[3]   The neuroprotective actions of corticotropin releasing hormone [J].
Bayatti, N ;
Behl, C .
AGEING RESEARCH REVIEWS, 2005, 4 (02) :258-270
[4]   Corticotropin-releasing hormone-mediated induction of intracellular signaling pathways and brain-derived neurotrophic factor expression is inhibited by the activation of the endocannabinoid system [J].
Bayatti, N ;
Hermann, H ;
Lutz, B ;
Behl, C .
ENDOCRINOLOGY, 2005, 146 (03) :1205-1213
[5]   Brain region-specific neuroprotective action and signaling of corticotropin-releasing hormone in primary neurons [J].
Bayatti, N ;
Zschocke, J ;
Behl, C .
ENDOCRINOLOGY, 2003, 144 (09) :4051-4060
[6]   Long-term variations of AP-1 composition after CRH stimulation:: consequence on POMC gene regulation [J].
Becquet, D ;
Guillaumond, F ;
Bosler, O ;
François-Bellan, AM .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2001, 175 (1-2) :93-100
[7]  
Behan DP, 1996, MOL PSYCHIATR, V1, P265
[8]   HYDROGEN-PEROXIDE MEDIATES AMYLOID-BETA PROTEIN TOXICITY [J].
BEHL, C ;
DAVIS, JB ;
LESLEY, R ;
SCHUBERT, D .
CELL, 1994, 77 (06) :817-827
[9]   Beyond NMDA and AMPA glutamate receptors: emerging mechanisms for ionic imbalance and cell death in stroke [J].
Besancon, Elaine ;
Guo, Shuzhen ;
Lok, Josephine ;
Tymianski, Michael ;
Lo, Eng H. .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2008, 29 (05) :268-275
[10]  
Blanc EM, 1998, J NEUROCHEM, V70, P958